Dipna Pharmachem Board Approves FY26 Audited Financial Results

Dipna Pharmachem Ltd announced the outcome of its Board Meeting held on July 2, 2026. The board approved the audited financial results for the quarter and year ended March 31, 2026. Key financial highlights for the year ended March 31, 2026, include total income of ₹12,910.87 Lakhs and a net profit of ₹263.19 Lakhs. The company also approved the statement of deviations for the proceeds of a preferential issue of convertible warrants. The meeting commenced at 4:00 PM and concluded at 8:00 PM at the company's registered office in Ahmedabad.